Polymeric micelles with doxorubicin bound through hydrazon bond - A new promising antitumor drug delivery system
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61389013%3A_____%2F07%3A00375205" target="_blank" >RIV/61389013:_____/07:00375205 - isvavai.cz</a>
Alternative codes found
RIV/61388971:_____/07:00375205
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Polymeric micelles with doxorubicin bound through hydrazon bond - A new promising antitumor drug delivery system
Original language description
The work deals of polymeric micelles with doxorubicin bound through hydrazon bond- a new promising antitumour drug delivery system. One of the promising approaches in the therapy of ulcerative colitis is administration of butyrate, an energy source for colonocytes, into the lumen of the colon. This study investigates the effect of butyrate producing bakterium Clostridium tyrobutyricum on dextran sodium sulphate (DSS)-induced colitis in mice. Immunocompetent BALB/c and immunodeficient severe combined immunodeficiency (SCID) mice reared in specific-pathogen-free (SPF) conditions were treated intrarectally with C. tyrobutyricum 1 week prior to the induction of DSS colitis and during oral DSS treatment.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
EC - Immunology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/KAN200200651" target="_blank" >KAN200200651: Nanoparticulate and supramolecular systems for targeted drug delivery</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2007
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů